Guangdong Biolight Meditech Co Ltd (300246) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangdong Biolight Meditech Co Ltd (300246) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥62.62 Million ≈ $9.16 Million USD) by net assets (CN¥1.29 Billion ≈ $188.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Guangdong Biolight Meditech Co Ltd (300246) defensive interval to measure how many days the company can operate on defensive assets alone.
Guangdong Biolight Meditech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Guangdong Biolight Meditech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Guangdong Biolight Meditech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Biolight Meditech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Era Co Ltd
SHE:002641
|
0.002x |
|
Lahav LR Real Estate Ltd
TA:LAHAV
|
0.011x |
|
Isgec Heavy Engineering Limited
NSE:ISGEC
|
0.154x |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880
|
0.021x |
|
Jiangsu Huaxicun Co Ltd
SHE:000936
|
0.013x |
|
Shenzhen Hirisun Technology Inc
SHE:300277
|
0.060x |
|
China Fortune Land Development Co Ltd
SHG:600340
|
0.076x |
|
SAMPYO Cement Co. Ltd
KQ:038500
|
0.061x |
Annual Cash Flow Conversion Efficiency for Guangdong Biolight Meditech Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Guangdong Biolight Meditech Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 300246 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.21 Billion ≈ $177.38 Million |
CN¥90.44 Million ≈ $13.23 Million |
0.075x | +1215.40% |
| 2024-12-31 | CN¥1.29 Billion ≈ $188.93 Million |
CN¥-8.64 Million ≈ $-1.26 Million |
-0.007x | -107.20% |
| 2023-12-31 | CN¥1.39 Billion ≈ $203.25 Million |
CN¥129.05 Million ≈ $18.88 Million |
0.093x | -0.80% |
| 2022-12-31 | CN¥1.50 Billion ≈ $219.85 Million |
CN¥140.72 Million ≈ $20.59 Million |
0.094x | +15.30% |
| 2021-12-31 | CN¥992.38 Million ≈ $145.22 Million |
CN¥80.61 Million ≈ $11.80 Million |
0.081x | -81.59% |
| 2020-12-31 | CN¥1.03 Billion ≈ $151.14 Million |
CN¥455.78 Million ≈ $66.70 Million |
0.441x | +217.50% |
| 2019-12-31 | CN¥585.84 Million ≈ $85.73 Million |
CN¥81.43 Million ≈ $11.92 Million |
0.139x | +6.49% |
| 2018-12-31 | CN¥622.19 Million ≈ $91.05 Million |
CN¥81.21 Million ≈ $11.88 Million |
0.131x | +0.02% |
| 2017-12-31 | CN¥554.08 Million ≈ $81.08 Million |
CN¥72.31 Million ≈ $10.58 Million |
0.130x | +29.53% |
| 2016-12-31 | CN¥504.27 Million ≈ $73.79 Million |
CN¥50.81 Million ≈ $7.43 Million |
0.101x | +63.51% |
| 2015-12-31 | CN¥460.87 Million ≈ $67.44 Million |
CN¥28.40 Million ≈ $4.16 Million |
0.062x | -37.68% |
| 2014-12-31 | CN¥427.94 Million ≈ $62.62 Million |
CN¥42.31 Million ≈ $6.19 Million |
0.099x | +42.54% |
| 2013-12-31 | CN¥393.88 Million ≈ $57.64 Million |
CN¥27.32 Million ≈ $4.00 Million |
0.069x | -35.30% |
| 2012-12-31 | CN¥377.93 Million ≈ $55.30 Million |
CN¥40.52 Million ≈ $5.93 Million |
0.107x | +30.72% |
| 2011-12-31 | CN¥354.32 Million ≈ $51.85 Million |
CN¥29.06 Million ≈ $4.25 Million |
0.082x | -81.60% |
| 2010-12-31 | CN¥89.93 Million ≈ $13.16 Million |
CN¥40.09 Million ≈ $5.87 Million |
0.446x | +73.55% |
| 2009-12-31 | CN¥66.94 Million ≈ $9.80 Million |
CN¥17.19 Million ≈ $2.52 Million |
0.257x | -5.70% |
| 2008-12-31 | CN¥46.53 Million ≈ $6.81 Million |
CN¥12.68 Million ≈ $1.85 Million |
0.272x | -- |
About Guangdong Biolight Meditech Co Ltd
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, el… Read more